Pharmaceutical NPDES Wastewater Analysis
In 1998 the EPA promulgated specific final effluent limitation guidelines and standards for pollutants from Pharmaceutical manufacturing facilities. The regulation identifies four industrial process subcategories Fermentation, Extraction, Chemical Synthesis and Mixing, Compounding or Formulating. A description of the standard and a list of conventional and non-conventional wastewater pollutants are found in 40 CFR 439 under the Clean Water Act (CWA). This guideline along with Part 136 defines the appropriate methods of analysis for these pollutants.
Pace Analytical Services has over 25 years experience with the collection and analysis of industrial wastewater. We serve a wide variety of industrial manufacturing facilities including pharmaceutical production. Pace Analytical has invested in specialized laboratory equipment for the monitoring of pollutants for this regulation. Our services include EPA 500, 600 and 1600 series methods.
- Method 524.2 - Volatile Organic Compounds by Purge & Trap GC/MS
- Method 624 - Volatile Organic Compounds by Purge & Trap GC/MS
- Method 625 - Semi-Volatile Organic Compounds by GC/MS
- Method 1666 - Pharmaceutical Volatile Organic Compounds by Isotope Dilution GC/MS
- Method 1667 - Formaldehyde by HPLC
- Method 1671 - Alcohols and Amines by GC/FID
- Pharmaceutical Compounding & Manufacturing Support Services
Analytical Chemistry, Microbiological Testing and Process Monitoring
USP, JP and EP Compendium Methods, cGMP/GLP Compliant